News | February 21, 2022
Corbevax receives EUA for 12-18 age group
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
It has also been granted permission to conduct trials for booster dose
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
The list of kids with co-morbidities eligible for vaccination would be announced by the government
It is a recombinant nanoparticle protein-based vaccine
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
The trial will be conducted across eight sites in Maharashtra
Subscribe To Our Newsletter & Stay Updated
